CLOROX COMPANY (CLX)
US1890541097 - Common Stock
Taking everything into account, CLX scores 4 out of 10 in our fundamental rating. CLX was compared to 12 industry peers in the Household Products industry. CLX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CLX is valied quite expensively at the moment, while it does show a decent growth rate. Finally CLX also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
CLX had positive earnings in the past year.
CLX had a positive operating cash flow in the past year.
In the past 5 years CLX has always been profitable.
Each year in the past 5 years CLX had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.13%, CLX is doing worse than 83.33% of the companies in the same industry.
CLX has a better Return On Equity (263.74%) than 91.67% of its industry peers.
With a Return On Invested Capital value of 16.92%, CLX perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLX is in line with the industry average of 14.40%.
The 3 year average ROIC (15.45%) for CLX is below the current ROIC(16.92%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.13% | ||
| ROE | 263.74% | ||
| ROIC | 16.92% |
ROA(3y)7.07%
ROA(5y)10.47%
ROE(3y)107.86%
ROE(5y)114.74%
ROIC(3y)15.45%
ROIC(5y)17.08%
1.3 Margins
Looking at the Profit Margin, with a value of 3.33%, CLX is doing worse than 83.33% of the companies in the same industry.
In the last couple of years the Profit Margin of CLX has declined.
The Operating Margin of CLX (13.15%) is comparable to the rest of the industry.
CLX's Operating Margin has declined in the last couple of years.
CLX has a better Gross Margin (42.24%) than 66.67% of its industry peers.
CLX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.15% | ||
| PM (TTM) | 3.33% | ||
| GM | 42.24% |
OM growth 3Y-16.55%
OM growth 5Y-9.83%
PM growth 3Y-47.54%
PM growth 5Y-31.57%
GM growth 3Y-4.8%
GM growth 5Y-2.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLX is creating value.
Compared to 1 year ago, CLX has more shares outstanding
Compared to 5 years ago, CLX has less shares outstanding
Compared to 1 year ago, CLX has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.49 indicates that CLX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.49, CLX is in line with its industry, outperforming 50.00% of the companies in the same industry.
The Debt to FCF ratio of CLX is 4.55, which is a neutral value as it means it would take CLX, 4.55 years of fcf income to pay off all of its debts.
CLX has a worse Debt to FCF ratio (4.55) than 75.00% of its industry peers.
A Debt/Equity ratio of 28.47 is on the high side and indicates that CLX has dependencies on debt financing.
The Debt to Equity ratio of CLX (28.47) is worse than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 28.47 | ||
| Debt/FCF | 4.55 | ||
| Altman-Z | 3.49 |
ROIC/WACC2.1
WACC8.07%
2.3 Liquidity
A Current Ratio of 0.90 indicates that CLX may have some problems paying its short term obligations.
CLX has a Current ratio of 0.90. This is in the lower half of the industry: CLX underperforms 75.00% of its industry peers.
CLX has a Quick Ratio of 0.90. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
CLX's Quick ratio of 0.53 is on the low side compared to the rest of the industry. CLX is outperformed by 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 38.62% over the past year.
Measured over the past years, CLX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.03% on average per year.
CLX shows a small growth in Revenue. In the last year, the Revenue has grown by 0.53%.
CLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.83% yearly.
EPS 1Y (TTM)38.62%
EPS 3Y-11.53%
EPS 5Y-2.03%
EPS Q2Q%13.25%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y3.21%
Revenue growth 5Y3.83%
Sales Q2Q%-5.27%
3.2 Future
Based on estimates for the next years, CLX will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.44% on average per year.
Based on estimates for the next years, CLX will show a small growth in Revenue. The Revenue will grow by 2.44% on average per year.
EPS Next Y17.66%
EPS Next 2Y13.31%
EPS Next 3Y11.06%
EPS Next 5Y9.44%
Revenue Next Year-1.01%
Revenue Next 2Y0.91%
Revenue Next 3Y1.64%
Revenue Next 5Y2.44%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 22.32 indicates a rather expensive valuation of CLX.
CLX's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 24.41. CLX is around the same levels.
A Price/Forward Earnings ratio of 20.60 indicates a rather expensive valuation of CLX.
CLX's Price/Forward Earnings is on the same level as the industry average.
CLX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.32 | ||
| Fwd PE | 20.6 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLX is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLX indicates a slightly more expensive valuation: CLX is more expensive than 66.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.33 | ||
| EV/EBITDA | 15.87 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.26
PEG (5Y)N/A
EPS Next 2Y13.31%
EPS Next 3Y11.06%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.52%, CLX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.52, CLX pays a better dividend. On top of this CLX pays more dividend than 91.67% of the companies listed in the same industry.
CLX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.52% |
5.2 History
The dividend of CLX is nicely growing with an annual growth rate of 6.15%!
CLX has been paying a dividend for at least 10 years, so it has a reliable track record.
CLX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.15%
Div Incr Years33
Div Non Decr Years33
5.3 Sustainability
CLX pays out 246.67% of its income as dividend. This is not a sustainable payout ratio.
CLX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP246.67%
EPS Next 2Y13.31%
EPS Next 3Y11.06%
CLOROX COMPANY
NYSE:CLX (7/26/2024, 7:22:36 PM)
After market: 134.24 -0.37 (-0.27%)134.61
+1.26 (+0.94%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap16.72B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.52% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.32 | ||
| Fwd PE | 20.6 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.26
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.13% | ||
| ROE | 263.74% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 13.15% | ||
| PM (TTM) | 3.33% | ||
| GM | 42.24% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 28.47 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)38.62%
EPS 3Y-11.53%
EPS 5Y
EPS Q2Q%
EPS Next Y17.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.53%
Revenue growth 3Y3.21%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y